Ocular surface inflammation induced by Propionibacterium acnes

Cornea

Volumn 21, Issue 8, 2002, Pages 812-817

  Suzuki, Tomo ^a   Sano, Yoichiro ^a   Sasaki, Osamu ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cornea; Delayed type hypersensitivity; Inflammation; Propionibacterium acnes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EOSIN; HEMATOXYLIN; PHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; CELL INFILTRATION; CONTROLLED STUDY; CORNEA STROMA; DELAYED HYPERSENSITIVITY; EAR; EDEMA; FEMALE; HISTOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MONONUCLEAR CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RAT; RAT STRAIN; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORNEAL STROMA; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HYPERSENSITIVITY, DELAYED; KERATITIS; MODELS, ANIMAL; PROPIONIBACTERIUM ACNES; RATS; RATS, INBRED LEW;

EID: 0036827686     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200211000-00017     Document Type: Article

References (42)

1. Kligman AM. An overview of acne. J Invest Dermatol 1974;62:268-87.
2. Meisler DM, Palestine AG, Vastine DW, et al. Chronic Propionibacterium endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 1986;102:733-9.
3. Zaidman GW. Propionibacterium acnes Keratitis. Am J Ophthalmol 1992;113:596-8.
4. Underdahl JP, Florakis GJ, Braunstein RE, et al. Propionibacterium acnes as a causative of visually significant corneal ulcers. Cornea 2000;19:451-4.
5. Perkins RE, Kundsin RB, Pratt MV, et al. Bacteriology of normal and infected conjunctiva. J Clin Microbiol 1975;1:147-9.
6. Brook I, Pettit TH, Martin WJ, et al. Anaerobic and aerobic bacteriology of acute conjunctivitis. Ann Ophthalmol 1979;11:389-93.
7. Dougherty JM, McCulley JM. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984;68:524-8.
8. Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea 1991;10:50-3.
9. McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U K 1986;105:314-8.
10. Valenton MJ, Okumoto M. Toxin producing strains of Staphylococcus epidermidis (albus). Isolates from patients with staphylococcic blepharoconjunctivitis. Arch Ophthalmol 1973;89:186-9.
11. Mondino BJ, Caster AI, Dethlefs B. A rabbit model of staphylococcal blepharitis. Arch Ophthalmol 1987;105:409-12.
12. Ficker L, Ramakrishnan M, Seal D, et al. Role of cell-mediated immunity to staphylococci in blepharitis. Am J Ophthalmol 1991;111:473-9.
13. Thygeson P. The etiology and treatment of phlyctenular keratoconjunctivitis. The Estelle L. Doheny Lecture. Am J Ophthalmol 1951;34:1217-36.
14. Thygeson P. Complications of staphylococcic blepharitis. Am J Ophthalmol 1969;68:446-9.
15. Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol 1977;95:812-26.
16. Mondino BJ, Kowalski R, Ratajczak HV, et al. Rabbit model of phlyctenulosis and catarrhal infiltrates. Arch Ophthalmol 1981;99:891-5.
17. Hara J, Yasuda F, Higashitsutsumi M. Preoperative disinfection of the conjunctival sac in cataract surgery. Ophthalomologica 1997;211(suppl 1):62-7.
18. Suzuki T, Yokoi N, Sano Y, et al. Investigation of the causative bacterium in phlyctenular keratitis. J Eye 1998;15:1151-3.
19. Webster GF, Leyden JJ, Norman ME, et al. Complement activation in acne vulgaris: In vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immunol 1978;22:523-9.
20. Webster GF, Nilsson UR, McArthur WP. Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions. Inflammation 1981;5:165-76.
21. Puhvel SM, Sakamoto M. The chemoattractant properties of comedonal components. J Invest Dermatol 1978;71:324-9.
22. Webster GF, Leyden JJ. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980;4:261-9.
23. Webster GF, Leyden JJ, Tsai CC, et al. Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from patients with inflammatory acne patients. J Invest Dermatol 1980;74:398-401.
24. Knop J, Riechmann R, Macher E. Modulation of suppressor mechanism in allergic contact dermatitis: II. Inhibition of suppressor T-lymphocytes by Corynebacterium parvum. J Invest Dermatol 1981;76:396-9.
25. Knop J, Riechmann R, Macher E. Modulation of suppressor mechanism in allergic contact dermatitis: IV. Selective inhibition of suppressor T-lymphocytes by serum obtained from Corynebacterium parvum treated mice. J Invest Dermatol 1981;77:469-73.
26. Senaldi G, Yin S, Shaklee CL, et al. Corynebacterium parvum and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol 1996;157:5022-6.
27. Yi ES, Lee H, Suh YK, et al. Experimental extrinsic allergic alveolitis and pulmonary angitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am J Pathol 1996;149:1303-12.
28. Kersey P, Sussman M, Dahl M. Delayed skin test reactivity to Propionibacterium acnes correlates with severity of inflammation in acne vulgaris. Br J Dermatol 1980;103:651-5.
29. Mizuno K, Clark AF, Streilein JW. Anterior chamber-associated immune deviation induced by soluble antigens. Invest Ophthalmol Vis Sci 1989;30:1112-9.
30. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice - Evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992;54:694-704.
31. Abbas AK. Effector mechanism of T cell-mediated immune reactions. In: Abbas AK, Lichtman AH, Pober JS, eds. Cellular and Molecular Immunology, 3rd Ed. Philadelphia: WB Saunders, 1997:279-96.
32. Webster GF, Leyden JJ, Musson RA, et al. Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro. Infect Immunol 1985;49:116-21.
33. Spector WG, Reichhold N, Ryan GB. Degradation of granulomainducing microorganisms by macrophages. J Pathol 1970;101:339-54.
34. Abu El-Asrar AM, Van Den Oord JJ, Geboes K, et al. Phenotypic characterization of inflammatory cells in phlyctenular eye disease. Doc Ophthalmol 1989;70:353-62.
35. Mondino BJ, Adamu SA, Pitchekian-Halabi H. Antibody studies in a rabbit model of corneal phlyctenulosis and catarrhal infiltrates related to Staphylococcus aureus. Invest Ophthalmol Vis Sci 1991;32:1854-63.
36. Gibson WS. The etiology of phlyctenular conjunctivitis. Am J Dis Child 1918;15:81-115.
37. Karvonen SL, Rasanen L, Cunliffe WJ, et al. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fluminans. Dermatology 1994;189:344-9.
38. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999;354:120-3.
39. Tachibana M, Kobayashi Y, Kasukabe T, et al. Expression of androgen receptor in mouse eye tissues. Invest Ophthalmol Vis Sci 2000;41:64-6.
40. Tachibana M, Kasukabe T, Kobayashi Y, et al. Expression of estrogen receptor α and β in the mouse cornea. Invest Ophthalmol Vis Sci 2000;41:668-70.
41. Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res 2001;22:28-33.
42. 3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci 2000;41:154-8.